These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 136058)

  • 41. Binding of thrombin to antithrombin III.
    Abildgaard U
    Scand J Clin Lab Invest; 1969 Aug; 24(1):23-7. PubMed ID: 5374920
    [No Abstract]   [Full Text] [Related]  

  • 42. Plasma thrombin-antithrombin III complex is associated with the severity of experimental autoimmune encephalomyelitis.
    Inaba Y; Ichikawa M; Inoue A; Itoh M; Kyogashima M; Sekiguchi Y; Nakamura S; Komiyama A; Koh C
    J Neurol Sci; 2001 Apr; 185(2):89-93. PubMed ID: 11311288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemostatic indices in healthy foals from birth to one month of age.
    Barton MH; Morris DD; Crowe N; Collatos C; Prasse KW
    J Vet Diagn Invest; 1995 Jul; 7(3):380-5. PubMed ID: 7578455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass.
    Nguyen NT; Owings JT; Gosselin R; Pevec WC; Lee SJ; Goldman C; Wolfe BM
    Arch Surg; 2001 Aug; 136(8):909-16. PubMed ID: 11485526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [THE PHYSIOPATHOLOGY OF FIBRINOLYSIS AND ITS CLINICAL AND THERAPEUTIC APPLICATIONS].
    SAMAMA M
    Transfusion (Paris); 1964; 7():99-125. PubMed ID: 14168287
    [No Abstract]   [Full Text] [Related]  

  • 47. Serial changes in coagulant activities after thrombolytic therapy for acute myocardial infarction.
    Goto S; Kawai Y; Abe S; Takahashi E; Handa S; Ogawa S; Watanabe K; Hori S; Ikeda Y
    Angiology; 1994 Apr; 45(4):273-81. PubMed ID: 8161005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemostatic changes in patients with liver cirrhosis.
    Ho CH; Hou MC; Lin HC; Lee FY; Wu JC; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):376-82. PubMed ID: 10389296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemostatic abnormalities may predict chronic hypertension after preeclampsia.
    Bremme K; Blombäck M
    Gynecol Obstet Invest; 1996; 41(1):20-6. PubMed ID: 8821879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.
    Goodwin CA; Kakkar VV; Scully MF
    Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):613-8. PubMed ID: 1531588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemic hemorrhagic fever. The mechanism of coagulation and fibrinolysis.
    Xiang LB; Zhang ZY; Chen JM; Xiang JM; Cosgriff TM
    Chin Med J (Engl); 1990 May; 103(5):391-5. PubMed ID: 1975230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of coagulation and fibrinolysis in childhood diarrhoea-associated haemolytic uraemic syndrome.
    Nevard CH; Jurd KM; Lane DA; Philippou H; Haycock GB; Hunt BJ
    Thromb Haemost; 1997 Dec; 78(6):1450-5. PubMed ID: 9423793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
    Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
    Arnesen H
    J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
    [No Abstract]   [Full Text] [Related]  

  • 55. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
    [No Abstract]   [Full Text] [Related]  

  • 56. [The state of prothrombin, plasminogen and fibrinogen in the newborn infant].
    Potron G; Droulle C; Behar C; Leroux B; Ledoyen MP; Mascre W
    Pathol Biol (Paris); 1975 Dec; 23 suppl():56-62. PubMed ID: 4759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery.
    Nishiyama T; Yokoyama T; Yamashita K
    J Anesth; 2006; 20(3):179-82. PubMed ID: 16897236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of enzyme-linked immunosorbent assay to measure thrombin-antithrombin III complexes in horses with colic.
    Topper MJ; Prasse KW
    Am J Vet Res; 1996 Apr; 57(4):456-62. PubMed ID: 8712506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet antithrombins: role of thrombin binding and the release of platelet fibrinogen.
    Watanabe K; Chao FC; Tullis JL
    Br J Haematol; 1977 Jan; 35(1):123-33. PubMed ID: 869991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Serum levels of fibrinogen degradation products in patients with hepatic cirrhosis].
    Cristani A; Cioni G; Minetto G; Di Pancrazio L; Anderlini D; Grandi S; Vezzelli C; Zirilli E; Zeneroli ML; Ventura E
    Recenti Prog Med; 1987 Oct; 78(10):431-3. PubMed ID: 3432720
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.